Abstract
RNA-RNA in situ hybridization was used to study the frequency of cells producing mRNA for IL-2 and IL-2-R in T lymphocytes stimulated by either of three mitogens: anti-CD3, anti-CD28, or PHA. Both CD4+ and CD8+ T cells expressed transcripts for IL-2 and the low-affinity IL-2-R when stimulated with these mitogens plus PMA. IL-2 transcripts peaked at 8-16 h, and IL-2-R at 24-40 h. Cyclosporin A (CSA) inhibited the synthesis of IL-2, but not IL-2-R mRNA, after stimulation by PHA or anti-CD3. However, higher concentrations of CSA were necessary to achieve 50-70% inhibition after stimulation with anti-CD28. At optimal points 12-22% of CD4+ and 5-13% of CD8+ cells expressed IL-2 mRNA, while 30-50% of cells of both subsets had IL-2-R mRNA. The IL-2 grain counts, which relate to the level of mRNA/cell, were higher in the CD4+ subset but could be increased several fold in the CD8+ subset in the presence of adherent accessory cells. The use of PMA as an accessory stimulus, in addition to adherent cells, greatly increased the frequency of lymphocytes with IL-2 mRNA and the amount of IL-2 activity in the culture medium, but the proliferative response was not significantly boosted. These observations indicate at the single cell level that many CD4+ or CD8+ lymphocytes can make IL-2 mRNA, and that the induction of IL-2 with several stimuli is reduced by CSA and enhanced by PMA.
MeSH Terms
Antibodies, Monoclonal/immunology
Antigen-Antibody Reactions
CD4-Positive T-Lymphocytes/physiology
Cyclosporins/pharmacology
Gene Expression Regulation/drug effects
Humans
In Vitro Techniques
Interleukin-2/genetics
Lymphocyte Activation/drug effects
Nucleic Acid Hybridization
RNA, Messenger/genetics
Receptors, Interleukin-2/genetics
T-Lymphocytes/drug effects,physiology
Time Factors
Chemicals
Antibodies, Monoclonal
Cyclosporins
Interleukin-2
RNA, Messenger
Receptors, Interleukin-2
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Granelli-Piperno A
Rockefeller University, New York, New York 10021.
References (10)
10 references, click to expand
-
A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.
J Immunol. 1981 Apr;126(4):1393-7
PMID: 6970774
-
Serological visualization of interleukin 2.
Science. 1983 Jun 10;220(4602):1188-90
PMID: 6344215
-
Human T-cell growth factor: partial amino acid sequence, cDNA cloning, and organization and expression in normal and leukemic cells.
Proc Natl Acad Sci U S A. 1984 Apr;81(8):2543-7
PMID: 6201860
-
Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription.
Proc Natl Acad Sci U S A. 1984 Aug;81(16):5214-8
PMID: 6332315
-
T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression.
Mol Cell Biol. 1987 Dec;7(12):4472-81
PMID: 2830495
-
Monoclonal antibody 9.3 and anti-CD11 antibodies define reciprocal subsets of lymphocytes.
Eur J Immunol. 1985 Dec;15(12):1164-8
PMID: 3936719
-
Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A.
J Exp Med. 1986 Apr 1;163(4):922-37
PMID: 2419474
-
Induction, suppression and superinduction of lymphokine mRNA in T lymphocytes.
Mol Immunol. 1987 May;24(5):409-19
PMID: 3116404
-
Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system.
Proc Natl Acad Sci U S A. 1987 Dec;84(23):8573-7
PMID: 2825196
-
Molecular cloning of cDNA encoding human interleukin-2 receptor.
Nature. 1984 Oct 18-24;311(5987):631-5
PMID: 6090949